Modafinil and the risk of cardiovascular events: Findings from three US claims databases.
Sigal KaplanEarl L GoehringSigal Melamed-GalBao-Anh Nguyen-KhoaHelena KnebelJudith K JonesPublished in: Pharmacoepidemiology and drug safety (2018)
Except for few CV outcomes, applying one common protocol generated consistent risk estimates of CV events following modafinil use across cohorts and databases.